Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'RITANSERIN R-55667' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 24 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Ninan, I; Kulkarni, SK
      Quinpirole, 8-OH-DPAT and ketanserin modulate catalepsy induced by high doses of atypical antipsychotics

      METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
    2. TANAKA H; OHNO Y; NAKAMURA M
      LOCALIZATION AND PHARMACOLOGICAL CHARACTERIZATION OF [H-3]PEROSPIRONE-BINDING SITES IN RAT-BRAIN

      General pharmacology
    3. TANAKA N; GOTO R; ITO R; HAYAKAWA M; OGAWA T; FUJIMOTO K
      [2-(OMEGA-PHENYLALKYL)PHENOXY]ALKYLAMINES - SYNTHESIS AND DUAL DOPAMINE(2) (D-2) AND 5-HYDROXYTRYPTAMINE(2) (5-HT2) RECEPTOR ANTAGONISTIC ACTIVITIES

      Chemical and Pharmaceutical Bulletin
    4. CARPENTER WT; ZITO JM; VITRAI J; VOLAVKA J
      HYPOTHESIS-TESTING - IS CLOZAPINES SUPERIOR EFFICACY DEPENDENT ON MODERATE D-2 RECEPTOR OCCUPANCY

      Biological psychiatry
    5. MCINTYRE R; YOUNG LT; HASEY G; PATELISSIOTIS I; JONES BD
      RISPERIDONE TREATMENT OF BIPOLAR DISORDER

      Canadian journal of psychiatry
    6. HAYASHI T; YOKOTA N; TAKAHASHI T; TAWARA Y; NISHIKAWA T; YANO T; FURUTANI M; FUJIKAWA T; HORIGUCHI J; YAMAWAKI S
      BENEFITS OF TRAZODONE AND MIANSERIN FOR PATIENTS WITH LATE-LIFE CHRONIC-SCHIZOPHRENIA AND TARDIVE-DYSKINESIA - AN ADD-ON, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY

      International clinical psychopharmacology
    7. OKUYAMA S; CHAKI S; YOSHIKAWA R; SUZUKI Y; OGAWA SI; IMAGAWA Y; KAWASHIMA N; IKEDA Y; KUMAGAI T; NAKAZATO A; NAGAMINE M; TOMISAWA K
      IN-VITRO AND IN-VIVO CHARACTERIZATION OF THE DOPAMINE D-4 RECEPTOR, SEROTONIN 5-HT2A RECEPTOR AND ALPHA-1-ADRENOCEPTOR ANTAGONIST -FLUOROPHENYL)-4-OXOBUTYL]PYRROLIDIN-3-YL]THIAZOLE (NRA0045)())

      The Journal of pharmacology and experimental therapeutics
    8. YU HJ; ISHIHARA K; MATSUBAYASHI H; AMANO T; SASA M
      EFFECTS OF PEROSPIRONE, A NOVEL ANTIPSYCHOTIC AGENT, ON THE DOPAMINERGIC-NEURONS IN THE RAT VENTRAL TEGMENTAL AREA

      Japanese Journal of Pharmacology
    9. OKUYAMA S; CHAKI S; KAWASHIMA N; SUZUKI Y; OGAWA S; KUMAGAI T; NAKAZATO A; NAGAMINE M; YAMAGUCHI K; TOMISAWA K
      THE ATYPICAL ANTIPSYCHOTIC PROFILE OF NRA0045, A NOVEL DOPAMINE D-4 AND 5-HYDROXYTRYPTAMINE(2A) RECEPTOR ANTAGONIST, IN RATS

      British Journal of Pharmacology
    10. REVELEY MA; DURSUN SM; ANDREWS H
      A COMPARATIVE TRIAL USE OF SULPIRIDE AND RISPERIDONE IN HUNTINGTONS-DISEASE - A PILOT-STUDY

      JOURNAL OF PSYCHOPHARMACOLOGY
    11. OHNO Y; ISHIDA K; ISHIBASHI T; IKEDA K; KATO T; NAKAMURA M
      EFFECTS OF CHRONIC TREATMENTS WITH SM-9018, A POTENTIAL ATYPICAL NEUROLEPTIC, ON BEHAVIORAL DOPAMINERGIC AND SEROTONERGIC SENSITIVITIES IN RATS

      General pharmacology
    12. OHNO Y; ISHIBASHI T; OKADA K; ISHIDA K; NAKAMURA M
      EFFECTS OF SUBCHRONIC TREATMENTS WITH SM-9018, A NOVEL 5-HT2 AND D2 ANTAGONIST ON DOPAMINE AND 5-HT RECEPTORS IN RATS

      Progress in neuro-psychopharmacology & biological psychiatry
    13. SVENSSON TH; MATHE JM; ANDERSSON JL; NOMIKOS GG; HILDEBRAND BE; MARCUS M
      MODE OF ACTION OF ATYPICAL NEUROLEPTICS IN RELATION TO THE PHENCYCLIDINE MODEL OF SCHIZOPHRENIA - ROLE OF 5-HT2 RECEPTOR AND ALPHA(1)-ADRENOCEPTOR ANTAGONISM

      Journal of clinical psychopharmacology
    14. CARPENTER WT
      SEROTONIN-DOPAMINE ANTAGONISTS AND TREATMENT OF NEGATIVE SYMPTOMS

      Journal of clinical psychopharmacology
    15. SEEGER TF; SEYMOUR PA; SCHMIDT AW; ZORN SH; SCHULZ DW; LEBEL LA; MCLEAN S; GUANOWSKY V; HOWARD HR; LOWE JA; HEYM J
      ZIPRASIDONE (CP-88,059) - A NEW ANTIPSYCHOTIC WITH COMBINED DOPAMINE AND SEROTONIN RECEPTOR ANTAGONIST ACTIVITY

      The Journal of pharmacology and experimental therapeutics
    16. WETZEL H; SZEGEDI A; HAIN C; WIESNER J; SCHLEGEL S; BENKERT O
      SEROQUEL (ICI-204-636), A PUTATIVE ATYPICAL ANTIPSYCHOTIC, IN SCHIZOPHRENIA WITH POSITIVE SYMPTOMATOLOGY - RESULTS OF AN OPEN CLINICAL-TRIAL AND CHANGES OF NEUROENDOCRINOLOGICAL AND EEG PARAMETERS

      Psychopharmacology
    17. MEERT TF
      PHARMACOLOGICAL EVALUATION OF ALCOHOL WITHDRAWAL-INDUCED INHIBITION OF EXPLORATORY-BEHAVIOR AND SUPERSENSITIVITY TO HARMINE-INDUCED TREMOR

      Alcohol and alcoholism
    18. GRANT S; FITTON A
      RISPERIDONE - A REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC POTENTIAL IN THE TREATMENT OF SCHIZOPHRENIA

      Drugs
    19. MARDER SR; MEIBACH RC
      RISPERIDONE IN THE TREATMENT OF SCHIZOPHRENIA

      The American journal of psychiatry
    20. MEGENS AAHP; AWOUTERS FHL; SCHOTTE A; MEERT TF; DUGOVIC C; NIEMEGEERS CJE; LEYSEN JE
      SURVEY ON THE PHARMACODYNAMICS OF THE NEW ANTIPSYCHOTIC RISPERIDONE

      Psychopharmacology
    21. ERESHEFSKY L; LACOMBE S
      PHARMACOLOGICAL PROFILE OF RISPERIDONE

      Canadian journal of psychiatry
    22. MATSUBARA S; MATSUBARA R; KUSUMI I; KOYAMA T; YAMASHITA I
      DOPAMINE-D(1), DOPAMINE-D(2) AND SEROTONIN(2) RECEPTOR OCCUPATION BY TYPICAL AND ATYPICAL ANTIPSYCHOTIC-DRUGS INVIVO

      The Journal of pharmacology and experimental therapeutics
    23. MEWSHAW RE; SILVERMAN LS; MATHEW RM; KAISER C; SHERRILL RG; CHENG MY; TIFFANY CW; KARBON EW; BAILEY MA; BOROSKY SA; FERKANY JW; ABREU ME
      BRIDGED GAMMA-CARBOLINES AND DERIVATIVES POSSESSING SELECTIVE AND COMBINED AFFINITY FOR 5-HT2 AND D(2)-RECEPTORS

      Journal of medicinal chemistry
    24. MARUOKA Y; OHNO Y; KATO T; HIROSE A; TATSUNO T; NAKAMURA M
      EFFECTS OF SM-9018, A POTENTIAL ATYPICAL NEUROLEPTIC, ON THE CENTRAL MONOAMINERGIC SYSTEM IN RATS

      Japanese Journal of Pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/10/20 alle ore 15:18:04